Abstract:Glioblastoma (GBM) is the most common and aggressive primary brain cancer in adults, characterized by robust infiltrative growth and invasion in the neural microenvironment. While various stromal cells including astrocytes, microglia, and vascular cells in the microenvironment communicate with GBM cells to promote growth and invasion, relatively less is known about the other critical component of the tumor stroma: the extracellular matrix (ECM). There are hundreds of ECM genes and affiliated adhesion and signaling components that comprise the brain matrisome; yet, we understand little about (i) the repertoire of matrisome genes and proteins that are expressed in GBM, (ii) the stromal and cancer cells of origin that express the different matrisome factors, and (iii) how these various components are interconnected to drive tumor malignancy. Here, we have used in situ single cell transcriptomics to analyze the spatial expression of nearly 350 genes that comprise the human matrisome. Our efforts have identified several differentially expressed matrisome genes with functions in ECM adhesion and signaling between cancer cells and stromal cells. In addition, matrisome genes with links to low grade glioma pathogenesis and progression to high grade GBM status have been spatially mapped. Collectively, these experiments reveal the single cell origins of differentially expressed ECM biomarkers as well as their spatial expression patterns in malignant brain tumors. These results may lead to new efforts to therapeutically inhibit matrisome components to benefit patients with malignant brain cancer.

In Situ Single-Cell Spatial Profiling of Matrisome Gene Expression in Glioblastoma